A phase IV, prospective. multicenter, open-label, mother-milk study to evaluate ofatumumab concentration in the breast milk of lactating women with relapsing forms of multiple sclerosis receiving ofatumumab (Kesimpta)

Is This Study For You?

Let's Get Started!

Details
Age
Child to Adult
Locations

Department Specific Free Standing Clinic
University of Colorado Hospital

Principal Investigator
Photograph of Anna Shah

Anna Shah

Study ID

Protocol Number: 24-0607

More information available at ClinicalTrials.gov: NCT06444113

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers